Literature DB >> 9932918

Multinodular goitre presenting as a clinical single nodule: how effective is hemithyroidectomy?

C Wadström1, J Zedenius, A Guinea, T Reeve, L Delbridge.   

Abstract

BACKGROUND: Patients who present with a single thyroid nodule that requires surgery will generally undergo hemithyroidectomy. If, however, the subsequent histological examination shows unsuspected multinodular change, there is a risk of recurrence in the remain ing lobe. The aim of this study was to determine the clinical outcome in patients who have had a hemithyroidectomy for a single thyroid nodule that was shown on subsequent histopathological examination to be part of a multinodular goitre.
METHODS: A survey was undertaken of patients who were identified from a thyroid surgery database with the following criteria: (i) hemithyroidectomy for clinical single nodule; and (ii) multinodular change on histopathology. Main outcome measures were clinical recurrence rate, the frequency of further thyroid surgery, and the efficacy of thyroxine treatment on recurrence.
RESULTS: In the 229 patients studied, the clinical recurrence rate was 12%. Fourteen of the 28 patients with recurrence required further surgery. Thyroxine therapy did not influence the recurrence rate.
CONCLUSION: When surgery for a clinically benign single thyroid nodule is indicated, hemithyroidectomy is an adequate surgical procedure in cases where the single nodule is subsequently found to be part of a multinodular goitre. Such patients can be reassured that the chance of clinical recurrence is low. Thyroxine replacement therapy appears not to prevent recurrence.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9932918     DOI: 10.1046/j.1440-1622.1999.01485.x

Source DB:  PubMed          Journal:  Aust N Z J Surg        ISSN: 0004-8682


  9 in total

1.  Prevalence of and risk factors for hypothyroidism after hemithyroidectomy: a systematic review and meta-analysis.

Authors:  Zhe Li; Yuxuan Qiu; Yuan Fei; Zhichao Xing; Jingqiang Zhu; Anping Su
Journal:  Endocrine       Date:  2020-07-07       Impact factor: 3.633

Review 2.  Less than total thyroidectomy for goiter: when and how?

Authors:  Özer Makay
Journal:  Gland Surg       Date:  2017-12

3.  Five-year follow-up of a randomized clinical trial of unilateral thyroid lobectomy with or without postoperative levothyroxine treatment.

Authors:  Marcin Barczyński; Aleksander Konturek; Filip Gołkowski; Alicja Hubalewska-Dydejczyk; Stanisław Cichoń; Wojciech Nowak
Journal:  World J Surg       Date:  2010-06       Impact factor: 3.352

4.  Total Thyroidectomy for Benign Thyroid Diseases: What is the Price to be Paid?

Authors:  Rajashekara Babu Gangappa; Manjunath Basavaraj Kenchannavar; Prashanth Basappa Chowdary; Adithya Malolan Patanki; Mahalakshmi Ishwar
Journal:  J Clin Diagn Res       Date:  2016-06-01

5.  Characteristics of well-differentiated thyroid cancer associated with multinodular goiter.

Authors:  Shih-Ping Cheng; Chien-Liang Liu; Chi-Yuan Tzen; Tsen-Long Yang; Kuo-Shyang Jeng; Tsang-Pai Liu; Jie-Jen Lee
Journal:  Langenbecks Arch Surg       Date:  2008-04-11       Impact factor: 3.445

Review 6.  Treatment and prevention of recurrence of multinodular goiter: an evidence-based review of the literature.

Authors:  Jacob Moalem; Insoo Suh; Quan-Yang Duh
Journal:  World J Surg       Date:  2008-07       Impact factor: 3.352

7.  Long-term sequelae of the less than total thyroidectomy procedures for benign thyroid nodular disease.

Authors:  Georgios Boutzios; Gerasimos Tsourouflis; Zoe Garoufalia; Krystallenia Alexandraki; Grigorios Kouraklis
Journal:  Endocrine       Date:  2018-10-09       Impact factor: 3.633

8.  Patient satisfaction following thyroidectomy in surgical mission: a prospective study.

Authors:  Mahir Gachabayov; Rifat Latifi
Journal:  Gland Surg       Date:  2019-08

9.  Hypothyroidism, new nodule formation and increase in nodule size in patients who have undergone hemithyroidectomy.

Authors:  Sibel Ertek; Reyhan Ünlü Ersoy; Cüneyd Anıl; Ozgür Demir; Murat Faik Erdoğan; Sevim Güllü; Dilek Berker; Kamile Gül; Uğur Unlütürk; Gürbüz Erdoğan
Journal:  Arch Med Sci       Date:  2012-05-09       Impact factor: 3.318

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.